Address
Email address
Phone number
Website
Name
sihtasutus Tartu Ülikooli Kliinikum
Registry code
90001478
VAT number
EE100506239
Type
SA - Foundation
Status
Registered
Foundation date
14.01.1999 (27)
Financial year
01.01-31.12
Activity
86101 - Hospitalisation services 86921 -
-
-
-
-
-
-
Submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Ahti Varblane
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Eero Vasar
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Maarjo Mändmaa
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Merike Saks
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Kristjan Vassil
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Heljo Pikhof
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Kaspar Kokk
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Urmas Klaas
| - | - | Exerciser of founder's rights, member of the supervisory board, board member |
| Hele Punga
| - | Contact person | - |
| Joel Starkopf
| - | Board member | Exerciser of founder's rights, member of the supervisory board, board member |
| Priit Perens
| - | Board member | Exerciser of founder's rights, member of the supervisory board, board member |
| Liis Salumäe
| - | Board member | Exerciser of founder's rights, member of the supervisory board, board member |
| Saima Hinno
| - | Board member | Beneficiary |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| aktsiaselts "Põlva Haigla" 10050157 | 51% - 800 112.60 EUR | - | - |
| AS Lõuna-Eesti Haigla 10833853 | 51% - 619 191.00 EUR | - | - |
| aktsiaselts Valga Haigla 10351752 | 51% - 1 000 059.50 EUR | - | - |
| 2019 31.03.2020 | 2020 16.04.2021 | 2021 01.04.2022 | 2022 31.03.2023 | 2023 28.03.2024 | 2024 12.05.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - |
| Net profit (loss) for the period | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Fixed Assets | - | - | - | - | - | - |
| Total Assets | - | - | - | - | - | - |
| Current Liabilities | - | - | - | - | - | - |
| Non Current Liabilities | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Share Capital | - | - | - | - | - | - |
| Equity | - | - | - | - | - | - |
| Employees | - | - | - | - | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 4 473 909 € | 21 878 536 € | 22 814 416 € | 5187 |
| 2025 Q3 | 4 528 139 € | 23 350 828 € | 24 712 060 € | 5187 |
| 2025 Q2 | 5 189 226 € | 22 017 832 € | 23 076 696 € | 5152 |
| 2025 Q1 | 5 232 380 € | 22 793 524 € | 23 644 992 € | 5111 |
| 2024 Q4 | 4 593 872 € | 19 932 040 € | 20 649 016 € | 5110 |
| 2024 Q3 | 5 501 667 € | 21 863 004 € | 22 437 052 € | 5110 |
| 2024 Q2 | 4 158 395 € | 18 841 072 € | 19 592 568 € | 5032 |
| 2024 Q1 | 5 297 994 € | 20 617 428 € | 21 229 640 € | 4952 |
| 2023 Q4 | 6 879 797 € | 18 485 312 € | 18 630 942 € | 4957 |
| 2023 Q3 | 4 959 209 € | 19 073 144 € | 19 684 358 € | 4957 |
| 2023 Q2 | 4 017 960 € | 15 607 479 € | 16 114 066 € | 4818 |
| 2023 Q1 | 3 810 800 € | 16 307 484 € | 17 087 060 € | 4793 |
| 2022 Q4 | 3 293 674 € | 14 550 538 € | 15 244 125 € | 4798 |
| 2022 Q3 | 2 770 462 € | 15 663 740 € | 16 439 860 € | 4798 |
| 2022 Q2 | 3 224 658 € | 13 916 173 € | 14 521 971 € | 4753 |
| 2022 Q1 | 3 052 784 € | 15 306 431 € | 15 992 989 € | 4749 |
